Navigation Links
Axia Value Chain Appoints John Christina Managing Director of Life Sciences Practice
Date:11/2/2011

ATLANTA, Nov. 2, 2011 /PRNewswire/ -- Axia Value Chain, a market leader in business transformation consulting, has appointed John Christina as Managing Director of their Life Sciences and Health Care Practice Group. In his new role, Mr. Christina will lead efforts with global clients in the Health Care and Life Science industry and be responsible for business development, consulting services, practice development, and service offerings concentrating on alignment of organizational operations with business strategies, supply chain management, and optimization of the value chain.

"We invest seriously to bring cutting-edge innovation for the management practices of the life sciences value chain due to complexity of this critical component of the global healthcare ecosystem," said Rodrigo Cambiaghi, President and COO of Axia Value Chain, NA. "Our vast experience and powerful value proposition for the sector has promoted significant and sustainable results for our clients worldwide and now John will lead our efforts to further develop our sector footprint in North America."

Prior to joining Axia Value Chain, Mr. Christina was the account partner for a large health care client while at UST Global. A longtime Life Sciences and Health Care industry leader, Mr. Christina was also heavily involved in setting strategies for and managing relationships on behalf of the Life Sciences practice group at Deloitte Consulting.

About Axia Value Chain

Based in Atlanta, GA and Sao Paolo, Brazil, Axia Value Chain is a business transformation consultancy that applies innovative methodologies in aligning a given company's operations to their respective business strategies. In doing so, Axia leverages value chain concepts and patented methodologies in producing rapid results and creating sustainable value that serves as a competitive advantage for its customers.

Axia Value Chain currently employs over 200 people worldwide across such sectors as Aviation & Aerospace, Life Sciences & Health Care, Retail, and Fast Moving Consumer Goods (FMCG). Representative clients include Brasil Foods, Electrolux, Goodyear, Gerdau, Novartis, Proctor & Gamble and Renault.

Axia Value Chain Public Relations Contact:

Moira Mahoney
Phone: 404.478.7832
Fax: 404.478.7819
moira.mahoney@axiavaluechain.com
http://AxiaValueChain.com

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE Axia Value Chain
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Advanced Life Sciences Awarded U.S. Department of Defense Biodefense Contract Valued at up to $3.8 Million
2. Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market
3. Omaxe Infrastructure & Construction Private Ltd Receives LoI for Construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP With Construction Value of Approx 250 Crores
4. Sinobiomed Retains CB Capital Partners as Financial Advisor to Maximize Shareholder Value
5. US Neuropathic Pain Market Value Doubles to $5 Billion by 2018
6. ProSource 2.0 Offers Value, Savings for Lab Supplies
7. deCODE Receives Nasdaq Deficiency Notice Relating to Market Value
8. Five New Clinical Studies Show Value of Masimo PVI & PI
9. Environmental Power Corporation and Organix, Inc. Establish Alliance to Produce High Value Soil Amendment Products
10. Synvista Therapeutics Announces Data Further Demonstrating the Value of Haptoglobin Genotyping in Diabetic Patients During AHA Meeting
11. Frost & Sullivan Recognizes Martek Biosciences for Unique and Customer-Focused Strategies With Customer Value Enhancement Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... , Jan. 20, 2017 Aratana Therapeutics, Inc. ... focused on the licensing, development and commercialization of innovative ... Best Company in North America ... the award based on the FDA approval of ... tablets), ENTYCE ® (capromorelin oral solution) and NOCITA ...
(Date:1/20/2017)... January 20, 2017 http://www.Financialbuzz.com ... one of leading causes of death worldwide. There were ... number of cancer related deaths increased gradually over time, ... incidence rate of various cancers continues to drive demand ... report by Global Market Insights, Inc. cancer biological therapy ...
(Date:1/19/2017)... , Jan. 19, 2017 /PRNewswire -- WuXi AppTec, ... open-access capability and technology platform, today announced that ... biology focused preclinical drug discovery contract research organization ... become a wholly-owned subsidiary of WuXi, and will ... and providing greater services. The acquisition will further ...
(Date:1/19/2017)... 2017  ArmaGen, Inc., today announced that it ... chief executive officer, as well as a member ... ArmaGen more than 17 years of executive management ... biotherapeutics and pharmaceuticals. "Mathias is ... and skillset necessary to lead ArmaGen to its ...
Breaking Biology Technology:
(Date:1/11/2017)... , Jan. 11, 2017  Michael Johnson, co-founder of Visikol Inc. ... Group, Inc., has been named to the elite "Forbes 30 Under ... one of 600 people in 20 fields nationwide to be recognized ... the 15,000 applicants were selected. ... He is currently a PhD candidate at Rutgers University. ...
(Date:1/6/2017)...  Delta ID Inc., a leader in consumer-grade iris ... at CES® 2017. Delta ID has collaborated with Gentex ... use of iris scanning as a secure, reliable and ... a car, and as a way to elevate the ... Delta ID and Gentex will demonstrate (booth #7326 LVCC) ...
(Date:1/3/2017)... 3, 2017 Onitor, provider of digital health ... Track, an innovative biometric data-driven program designed to aid ... at the 2017 Consumer Electronics Show (CES) in ... the U.S., the World Health Organization (WHO), have identified ... adults who are overweight or obese. WHO also states ...
Breaking Biology News(10 mins):